These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
136 related articles for article (PubMed ID: 29138328)
21. HF10, an attenuated herpes simplex virus (HSV) type 1 clone, lacks neuroinvasiveness and protects mice against lethal challenge with HSV types 1 and 2. Mori I; Liu B; Goshima F; Ito H; Koide N; Yoshida T; Yokochi T; Kimura Y; Nishiyama Y Microbes Infect; 2005 Dec; 7(15):1492-500. PubMed ID: 16054416 [TBL] [Abstract][Full Text] [Related]
22. Genital herpes vaccines--cause for cautious optimism. Haddow LJ; Mindel A Sex Health; 2006 Mar; 3(1):1-4. PubMed ID: 16607967 [TBL] [Abstract][Full Text] [Related]
23. Reduced immune responses after vaccination with a recombinant herpes simplex virus type 1 vector in the presence of antiviral immunity. Lauterbach H; Ried C; Epstein AL; Marconi P; Brocker T J Gen Virol; 2005 Sep; 86(Pt 9):2401-2410. PubMed ID: 16099897 [TBL] [Abstract][Full Text] [Related]
24. Multicentre clinical trial with herpes simplex virus vaccine in recurrent herpes infection. Mastrolorenzo A; Tiradritti L; Salimbeni L; Zuccati G Int J STD AIDS; 1995; 6(6):431-5. PubMed ID: 8845402 [TBL] [Abstract][Full Text] [Related]
25. [Vaccines as an approach to the immunocorrection in herpetic infections]. Barinskiĭ IF; Alimbarova LM; Lazarenko AA; Makhmudov FR; Sergeev OV Vopr Virusol; 2014; 59(1):5-11. PubMed ID: 25065139 [TBL] [Abstract][Full Text] [Related]
26. A tale of 2 alpha-herpesviruses: lessons for vaccinologists. Rouse BT; Kaistha SD Clin Infect Dis; 2006 Mar; 42(6):810-7. PubMed ID: 16477558 [TBL] [Abstract][Full Text] [Related]
28. Herpes simplex: insights on pathogenesis and possible vaccines. Koelle DM; Corey L Annu Rev Med; 2008; 59():381-95. PubMed ID: 18186706 [TBL] [Abstract][Full Text] [Related]
30. Optimized DNA Vaccine Enhanced by Adjuvant IL28B Induces Protective Immune Responses Against Herpes Simplex Virus Type 2 in Mice. Zhou Y; Wang Z; Xu Y; Zhang Z; Hua R; Liu W; Jiang C; Chen Y; Yang W; Kong W Viral Immunol; 2017 Oct; 30(8):601-614. PubMed ID: 28650722 [TBL] [Abstract][Full Text] [Related]
31. A Herpes Simplex Virus Type 1 Human Asymptomatic CD8+ T-Cell Epitopes-Based Vaccine Protects Against Ocular Herpes in a "Humanized" HLA Transgenic Rabbit Model. Srivastava R; Khan AA; Huang J; Nesburn AB; Wechsler SL; BenMohamed L Invest Ophthalmol Vis Sci; 2015 Jun; 56(6):4013-28. PubMed ID: 26098469 [TBL] [Abstract][Full Text] [Related]
32. Therapeutic immunization with a mixture of herpes simplex virus 1 glycoprotein D-derived “asymptomatic” human CD8+ T-cell epitopes decreases spontaneous ocular shedding in latently infected HLA transgenic rabbits: association with low frequency of local PD-1+ TIM-3+ CD8+ exhausted T cells. Khan AA; Srivastava R; Chentoufi AA; Geertsema R; Thai NT; Dasgupta G; Osorio N; Kalantari M; Nesburn AB; Wechsler SL; BenMohamed L J Virol; 2015 Jul; 89(13):6619-32. PubMed ID: 25878105 [TBL] [Abstract][Full Text] [Related]
33. Ocular herpes simplex: changing epidemiology, emerging disease patterns, and the potential of vaccine prevention and therapy. Pepose JS; Keadle TL; Morrison LA Am J Ophthalmol; 2006 Mar; 141(3):547-557. PubMed ID: 16490506 [TBL] [Abstract][Full Text] [Related]
34. Immunotherapeutic activity of a recombinant combined gB-gD-gE vaccine against recurrent HSV-2 infections in a guinea pig model. Manservigi R; Boero A; Argnani R; Caselli E; Zucchini S; Miriagou V; Mavromara P; Cilli M; Grossi MP; Balboni PG; Cassai E Vaccine; 2005 Jan; 23(7):865-72. PubMed ID: 15603886 [TBL] [Abstract][Full Text] [Related]
35. Monoclonal antibodies to the distinct antigenic sites on glycoproteins C and B and their protective abilities in herpes simplex virus infection. Bystrická M; Petríková M; Zatovicová M; Soláriková L; Kostolanský F; Mucha V; Russ G Acta Virol; 1997 Feb; 41(1):5-12. PubMed ID: 9199708 [TBL] [Abstract][Full Text] [Related]
36. Development of prophylactic vaccines for genital and neonatal herpes. Jones CA; Cunningham AL Expert Rev Vaccines; 2003 Aug; 2(4):541-9. PubMed ID: 14711338 [TBL] [Abstract][Full Text] [Related]
37. Impact of Type I Interferon on the Safety and Immunogenicity of an Experimental Live-Attenuated Herpes Simplex Virus 1 Vaccine in Mice. Royer DJ; Carr MM; Chucair-Elliott AJ; Halford WP; Carr DJJ J Virol; 2017 Apr; 91(7):. PubMed ID: 28122977 [TBL] [Abstract][Full Text] [Related]
38. Evaluation of a novel serology algorithm to detect herpes simplex virus 1 or 2 antibodies. Zahariadis G; Severini A Sex Transm Dis; 2010 Nov; 37(11):696-9. PubMed ID: 20693937 [TBL] [Abstract][Full Text] [Related]